These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17168433)

  • 1. Primary glioblastoma multiforme in younger patients: a single-institution experience.
    Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
    Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database.
    Mak KS; Agarwal A; Qureshi MM; Truong MT
    Cancer Med; 2017 Jun; 6(6):1192-1200. PubMed ID: 28440040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma.
    Straube C; Kessel KA; Antoni S; Gempt J; Meyer B; Schlegel J; Schmidt-Graf F; Combs SE
    Radiat Oncol; 2020 May; 15(1):97. PubMed ID: 32375830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes and prognostic factors of infratentorial glioblastoma in the elderly.
    Chandra A; Lopez-Rivera V; Ryba B; Chandran AS; Brandel MG; Dono A; Sheinberg DL; Esquenazi YL; Aghi MK
    Clin Neurol Neurosurg; 2024 Jan; 236():108084. PubMed ID: 38141552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
    Baumgarten P; Prange G; Kamp MA; Monden D; Neef V; Schwarzer F; Dubinski D; Dinc N; Weber KJ; Czabanka M; Hattingen E; Ronellenfitsch MW; Steinbach JP; Senft C
    J Neurooncol; 2023 Dec; 165(3):509-515. PubMed ID: 38032426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shorter survival time of adolescents and young adult patients than older adults with spinal cord glioblastoma: a multicenter study.
    Inoue T; Endo T; Muto J; Umebayashi D; Mitsuhara T; Shigekawa S; Kanematsu R; Iwasaki M; Takami T; Hida K; Mizuno M; ;
    J Neurosurg Spine; 2024 Feb; 40(2):196-205. PubMed ID: 37976504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.
    Bauchet L; Mathieu-Daudé H; Fabbro-Peray P; Rigau V; Fabbro M; Chinot O; Pallusseau L; Carnin C; Lainé K; Schlama A; Thiebaut A; Patru MC; Bauchet F; Lionnet M; Wager M; Faillot T; Taillandier L; Figarella-Branger D; Capelle L; Loiseau H; Frappaz D; Campello C; Kerr C; Duffau H; Reme-Saumon M; Trétarre B; Daures JP; Henin D; Labrousse F; Menei P; Honnorat J; ; ; ;
    Neuro Oncol; 2010 Jul; 12(7):725-35. PubMed ID: 20364023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early progression of glioblastoma before radiotherapy.
    Datsenko PV; Kobyletskaya TM; Chuguev AS; Belikova AA; Gerasimov VA; Kaprin AD
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(3):40-46. PubMed ID: 37325825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing outcomes: neurosurgical resection in brain metastasis patients with poor Karnofsky performance score - a comprehensive survival analysis.
    Goldberg M; Mondragon-Soto MG; Altawalbeh G; Baumgart L; Gempt J; Bernhardt D; Combs SE; Meyer B; Aftahy AK
    Front Oncol; 2023; 13():1343500. PubMed ID: 38269027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopsy vs. extensive resection for first recurrence of glioblastoma: is a prospective clinical trial warranted?
    Dardis C; Ashby L; Shapiro W; Sanai N
    BMC Res Notes; 2015 Sep; 8():414. PubMed ID: 26341541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
    Kim N; Lee J; Nam DH; Lee JI; Seol HJ; Kong DS; Choi JW; Chong K; Lee WJ; Chang JH; Kang SG; Moon JH; Cho J; Lim DH; Yoon HI
    J Neurooncol; 2023 Nov; 165(2):261-268. PubMed ID: 37861921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients.
    Blakstad H; Mendoza Mireles EE; Kierulf-Vieira KS; Singireddy D; Mdala I; Heggebø LC; Magelssen H; Sprauten M; Johannesen TB; Leske H; Niehusmann P; Skogen K; Helseth E; Emblem KE; Vik-Mo EO; Brandal P
    J Neurooncol; 2024 Aug; 169(1):137-145. PubMed ID: 38762830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and social-economic inequalities in systemic chemotherapy use among adult glioblastoma patients following surgery and radiotherapy.
    Xu F; Hua X; Wang M; Cao W; Wang S; Xu C; Chen J; Gao Y; Chen L; Ni W
    Sci Rep; 2024 Aug; 14(1):19079. PubMed ID: 39154028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Postoperative Intravenous Cyclosporine Treatment on the Survival and Functional Performance Status of Patients With Glioblastoma: A Randomized, Triple-Blinded, Placebo-Controlled Clinical Trial.
    Shafizadeh M; Farzaneh F; Kankam SB; Jangholi E; Shafizadeh Y; Khoshnevisan A
    World Neurosurg; 2023 Aug; 176():e548-e556. PubMed ID: 37268192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma.
    Nizamutdinov D; Stock EM; Dandashi JA; Vasquez EA; Mao Y; Dayawansa S; Zhang J; Wu E; Fonkem E; Huang JH
    World Neurosurg; 2018 Jan; 109():e67-e74. PubMed ID: 28951270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive correlation between blood glucose and radiotherapy doses to the central gustatory system in Glioblastoma Multiforme patients.
    Duma MN; Oszfolk NI; Boeckh-Behrens T; Oechsner M; Zimmer C; Meyer B; Pfluger PT; Combs SE
    Radiat Oncol; 2019 Jun; 14(1):97. PubMed ID: 31174561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management and outcomes of glioblastoma: 20-year experience in a single Australian institution.
    Lenffer B; Ruben J; Senthi S; Millar J; Ong WL
    J Med Imaging Radiat Oncol; 2024 Mar; 68(2):208-216. PubMed ID: 37997616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consulting a neurosurgeon upon initial medical assessment reduces the time to the first surgery and potentially contributes to improved prognosis for glioblastoma patients.
    Kawauchi D; Ohno M; Miyakita Y; Takahashi M; Yanagisawa S; Omura T; Yoshida A; Kubo Y; Igaki H; Ichimura K; Narita Y
    Jpn J Clin Oncol; 2023 Nov; 53(11):1027-1033. PubMed ID: 37534529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Diagnosis and Surgical Intervention Within 3 Weeks From Symptom Onset Are Associated With Prolonged Survival of Patients With Glioblastoma.
    Kawauchi D; Ohno M; Miyakita Y; Takahashi M; Yanagisawa S; Omura T; Yoshida A; Kubo Y; Igaki H; Ichimura K; Narita Y
    Neurosurgery; 2022 Nov; 91(5):741-748. PubMed ID: 35951724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.
    Bunevicius A; Deltuva VP; Tamasauskas S; Smith T; Laws ER; Bunevicius R; Iervasi G; Tamasauskas A
    Oncotarget; 2017 Jan; 8(5):8648-8656. PubMed ID: 28055959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.